. Epidemiologic characteristics of dengue differ by region, and disease incidence varies by patient age. In Southeast Asia, incidence of dengue fever (DF) and dengue hemorrhagic fever (DHF) is highest among children (2, 3) ; in the Western Hemisphere, incidence of these diseases is higher among adults.
In Brazil, which has ≈80% of dengue cases in the Western Hemisphere, adults are at risk for dengue virus (DENV) infection (3, 4) . However, in 2007, a total of 53% of persons in Brazil hospitalized with DHF were children <15 years of age; this proportion was highest (65.4%) in children in northeastern Brazil (5) .
In Ceará, a state in northeastern Brazil, DENV-1 epidemics have occurred since 1987. DHF cases have been reported since 1994 when DENV-2 was identifi ed. In 2003, a severe DENV-3 epidemic occurred, and DHF incidence was high among adults (6) . However, since 2007, incidence of DENV infection has been highest among children (7) . To better understand factors that could affect this change in risk by age group, we studied the temporal progression of age distribution of persons with dengue during 1998-2008 in Ceará.
We used data for Ceará from the National System of Notifi able Diseases (DF and DHF cases), the Hospital Admission Data System (dengue hospitalizations) (8) , and the Central Public Health Laboratory (virus isolation). For each age group (<10, 10-19, 20-59, and >60 years), we calculated incidence of DF and hospitalization rate for DHF. We also calculated proportions of dengue serotypes per year (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . Medians for continuous variables were compared by using the Kruskal-Wallis test. Analyses were performed by using Epi Info version 6.0 software (Centers for Disease Control and Prevention, Atlanta, GA, USA).
From 1998 (10.8 cases/100,000 persons) through 2007 (236.7 cases/100,000 persons), DF incidence was lowest among persons <10 years of age. However, the incidence was highest (599.4 cases/100,000 persons) for this age group in 2008. In 2007, incidence among persons <10 years of age (236.7 cases/100,000 persons) was similar to that among persons 10-19, 20-59, and >60 years of age (305.6, 331.5, and 249.9 cases/100,000 persons, respectively).
Since 2007, the incidence of DHF among children was already higher (4,884 cases/100,000 persons) than among the other age groups (3,261, 3,387 and 2,789 cases/100,000 persons, respectively). In 2008, incidence of DHF among children was 8,992 cases/100,000 persons, which was 2× that among persons 10- (9) . Such a small difference cannot explain this change in the age group affected by dengue.
Second, the time when 3 serotypes circulated in Ceará may not have favored development of antibodies against DENV-3 in children <10 years of age, although they were susceptible to DENV-2. DENV-1 and DENV-2 were circulating in Ceará before 2002 and caused DF epidemics and a few DHF cases. However, these diseases occurred predominantly in adults. Conversely, children had little likelihood of being infected with DENV-2 because the incidence of dengue be- 
